Quanex Building Products Earnings Calls
| Release date | Dec 11, 2025 |
| EPS estimate | $0.500 |
| EPS actual | - |
| Revenue estimate | 472.619M |
| Revenue actual | - |
| Expected change | +/- 3.17% |
| Release date | Sep 04, 2025 |
| EPS estimate | $0.85 |
| EPS actual | $0.690 |
| EPS Surprise | -18.82% |
| Revenue estimate | 472.619M |
| Revenue actual | 495.273M |
| Revenue Surprise | 4.79% |
| Release date | Jun 05, 2025 |
| EPS estimate | $0.480 |
| EPS actual | $0.600 |
| EPS Surprise | 25.00% |
| Revenue estimate | 439.304M |
| Revenue actual | 452.478M |
| Revenue Surprise | 3.00% |
| Release date | Mar 10, 2025 |
| EPS estimate | -$0.0600 |
| EPS actual | $0.190 |
| EPS Surprise | 416.67% |
| Revenue estimate | 441.792M |
| Revenue actual | 400.044M |
| Revenue Surprise | -9.45% |
Last 4 Quarters for Quanex Building Products
Below you can see how NX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Mar 10, 2025 |
| Price on release | $20.42 |
| EPS estimate | -$0.0600 |
| EPS actual | $0.190 |
| EPS surprise | 416.67% |
| Date | Price |
|---|---|
| Mar 04, 2025 | $18.68 |
| Mar 05, 2025 | $19.50 |
| Mar 06, 2025 | $19.96 |
| Mar 07, 2025 | $20.22 |
| Mar 10, 2025 | $20.42 |
| Mar 11, 2025 | $18.54 |
| Mar 12, 2025 | $18.66 |
| Mar 13, 2025 | $19.13 |
| Mar 14, 2025 | $19.73 |
| 4 days before | 9.31% |
| 4 days after | -3.38% |
| On release day | -9.21% |
| Change in period | 5.62% |
| Release date | Jun 05, 2025 |
| Price on release | $17.09 |
| EPS estimate | $0.480 |
| EPS actual | $0.600 |
| EPS surprise | 25.00% |
| Date | Price |
|---|---|
| May 30, 2025 | $16.73 |
| Jun 02, 2025 | $16.30 |
| Jun 03, 2025 | $17.14 |
| Jun 04, 2025 | $17.15 |
| Jun 05, 2025 | $17.09 |
| Jun 06, 2025 | $18.90 |
| Jun 09, 2025 | $19.02 |
| Jun 10, 2025 | $20.19 |
| Jun 11, 2025 | $19.93 |
| 4 days before | 2.15% |
| 4 days after | 16.62% |
| On release day | 10.59% |
| Change in period | 19.13% |
| Release date | Sep 04, 2025 |
| Price on release | $20.91 |
| EPS estimate | $0.85 |
| EPS actual | $0.690 |
| EPS surprise | -18.82% |
| Date | Price |
|---|---|
| Aug 28, 2025 | $21.37 |
| Aug 29, 2025 | $21.27 |
| Sep 02, 2025 | $20.78 |
| Sep 03, 2025 | $20.09 |
| Sep 04, 2025 | $20.91 |
| Sep 05, 2025 | $18.18 |
| Sep 08, 2025 | $16.20 |
| Sep 09, 2025 | $15.29 |
| Sep 10, 2025 | $15.20 |
| 4 days before | -2.15% |
| 4 days after | -27.31% |
| On release day | -13.06% |
| Change in period | -28.87% |
| Release date | Dec 11, 2025 |
| Price on release | - |
| EPS estimate | $0.500 |
| EPS actual | - |
| Date | Price |
|---|---|
| Nov 11, 2025 | $13.11 |
| Nov 12, 2025 | $13.18 |
| Nov 13, 2025 | $13.06 |
| Nov 14, 2025 | $12.95 |
| Nov 17, 2025 | $12.23 |
Quanex Building Products Earnings Call Transcript Summary of Q3 2025
Quanex reported Q3 2025 results shaped by (1) a soft macro/demand environment (particularly U.S. R&R and new construction), (2) completion of a company resegmentation that triggered a noncash goodwill impairment, and (3) ongoing integration of the Tyman acquisition and associated synergies. Operational highlights: adjusted EBITDA rose to $70.3M (up 67% YoY) and adjusted EPS was $0.69; cash from operations was $60.7M and free cash flow $46.2M, enabling repayment of $51.25M of bank debt and opportunistic buybacks (100k shares, ~$2.1M). Tyman integration: management has staffed commercial and operational teams, is capturing synergies, and now expects approximately $45M of cost synergies over time (up from the initial $30M estimate), with additional revenue synergies targeted in a second phase. Headwinds: a $302.3M noncash goodwill impairment (accounting-driven, management says not reflective of long-term business fundamentals) materially drove a reported net loss of $276M (-$6.04/sh). Separately, tooling/equipment issues at the Monterrey, Mexico hardware facility caused roughly a $5M EBITDA hit in Q3 and are expected to pressure results into Q4; remediation (leadership changes, capital and process upgrades) is underway with tangible benefits expected in early FY2026. Updated FY2025 guidance: net sales ~ $1.82B, adjusted EBITDA ~ $235M, gross margin ~27%, SG&A ~$264M, adj D&A ~$58M, interest ~$53M, adjusted tax rate 24.5%, capex ~$75M, and free cash flow ~$80M. Financial position: net debt/last-12-month adjusted EBITDA ~2.6x (covenant flexibility remains). Investor takeaways: short-term demand softness and an accounting impairment weigh on reported results, but cash generation, deleveraging, higher expected synergies from the Tyman deal, and management’s remediation plan for Monterrey are positive catalysts for medium-term recovery once macro conditions (notably interest rates/consumer confidence) improve.
Sign In
Buy NX